Funder: National Institutes of Health (NIH)

Due Dates: November 17, 2025

Funding Amounts: No published ceiling or floor; budget should be reasonable and appropriate for project scope. Typical Phase II SBIR awards last up to 2-3 years.

Summary: Supports small businesses in implementing investigator-initiated clinical trials aligned with the NIAID mission, including high-risk and mechanistic studies.

Key Information: Only U.S. small businesses are eligible; foreign organizations are not eligible to apply.